Citigroup Inc Akero Therapeutics, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 17,118 shares of AKRO stock, worth $927,795. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,118

Previous 46,536 63.22%

Holding current value

$927,795

Previous $2.48 Million 67.3%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$42.18 - $54.33 $1.24 Million - $1.6 Million	-29,418 Reduced 63.22%	17,118 $812,000
Q2 2025 Aug 11, 2025	SELL	$34.04 - $56.28 $6.39 Million - $10.6 Million	-187,636 Reduced 80.13%	46,536 $2.48 Million
Q1 2025 May 12, 2025	BUY	$21.87 - $57.56 $3.2 Million - $8.42 Million	146,255 Added 166.36%	234,172 $9.48 Million
Q4 2024 Feb 12, 2025	BUY	$26.75 - $35.28 $963,963 - $1.27 Million	36,036 Added 69.46%	87,917 $2.45 Million
Q3 2024 Nov 12, 2024	BUY	$21.45 - $29.34 $485,027 - $663,436	22,612 Added 77.26%	51,881 $1.49 Million

Q2 2024 Aug 12, 2024	SELL	$18.31 - $24.62 $4.14 Million - $5.57 Million	-226,165 Reduced 88.54%	29,269 $686,000
Q1 2024 May 10, 2024	BUY	$17.76 - $31.18 $1.19 Million - $2.09 Million	66,982 Added 35.54%	255,434 $6.45 Million
Q4 2023 Feb 09, 2024	BUY	$11.38 - $50.33 $1.05 Million - $4.63 Million	91,962 Added 95.31%	188,452 $4.4 Million
Q3 2023 Nov 09, 2023	BUY	$41.19 - $52.25 $986,706 - $1.25 Million	23,955 Added 33.03%	96,490 $4.88 Million
Q2 2023 Aug 10, 2023	SELL	$36.89 - $56.88 $2.25 Million - $3.47 Million	-60,982 Reduced 45.67%	72,535 $3.39 Million
Q1 2023 May 11, 2023	BUY	$37.27 - $50.24 $1.88 Million - $2.54 Million	50,458 Added 60.75%	133,517 $5.11 Million
Q4 2022 Feb 09, 2023	BUY	$33.44 - $54.8 $2.7 Million - $4.43 Million	80,860 Added 3677.13%	83,059 $4.55 Million
Q3 2022 Nov 10, 2022	SELL	$10.15 - $34.05 $19,061 - $63,945	-1,878 Reduced 46.06%	2,199 $75,000
Q2 2022 Aug 10, 2022	SELL	$8.0 - $15.01 $69,936 - $131,217	-8,742 Reduced 68.2%	4,077 $39,000
Q1 2022 May 12, 2022	SELL	$12.97 - $22.26 $480,214 - $824,176	-37,025 Reduced 74.28%	12,819 $182,000
Q4 2021 Feb 10, 2022	BUY	$19.87 - $26.24 $368,846 - $487,093	18,563 Added 59.34%	49,844 $1.05 Million
Q3 2021 Nov 10, 2021	BUY	$18.65 - $25.46 $583,390 - $796,414	31,281 New	31,281 $699,000

Others Institutions Holding AKRO

# of Institutions

299

Shares Held

91.4M

Call Options Held

1.04M

Put Options Held

372K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.52B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account